Back to search
FDAFDA · Food and drugs·Recall number D-0061-2023

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01

Published November 23, 2022 · Recall initiated: November 10, 2022

Summary

FDA records drug Class II recall D-0061-2023, published November 23, 2022 and initiated November 10, 2022. Recalling firm: Par Formulations Private Limited; Status: Terminated; Reported quantity: 218 bottles/100 capsules per bottle; Lot: Lot #: 15429401, Exp. Date 08/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Par Formulations Private Limited
Distributor
Nationwide within the United States
Lot
Lot #: 15429401, Exp. Date 08/2023
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01 recalled?

Yes. FDA published recall D-0061-2023 on November 23, 2022. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter